MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
property and equipment
$55K
Net cash provided
by/(used) in investing...
$55K
Net decrease in
cash, cash...
-$4,663K
Canceled cashflow
$55K
Accrued expenses and
other current...
$2,586K
Depreciation and
amortization
$856K
Accounts payable
$644K
Share based
compensation
$556K
Prepaid expenses and
other current assets
-$529K
Non-cash lease expenses
$210K
Change in contingent
consideration
$84K
Non-cash interest
expense
$13K
Net cash used in
operating activities
-$3,366K
Effect of exchange
rates on cash, cash...
-$1,352K
Canceled cashflow
$5,478K
Net loss
-$5,534K
Unrealized foreign
exchange (gain)/loss
$1,714K
Deferred income
-$1,046K
Operating lease
liabilities
-$347K
Research and development
incentives receivable
$149K
Profit on sale of
property and equipment
$38K
Deferred tax benefit
-$16K
Back
Back
Cash Flow
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)
source: myfinsight.com